secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001213900-25-059084
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Oncology regains Nasdaq minimum bid price compliance
-----------------------------------------------------------

- Received Nasdaq compliance notice on June 26, 2025, for Listing Rule 5550(a)(2).
- Common stock closing bid price was $1.00+ for 12 consecutive trading days (June 6–24, 2025).
- Nasdaq considers the bid price deficiency matter closed.
- Company avoids delisting; its common stock remains listed on Nasdaq Capital Market.
- Ticker CTOR; compliance regained after previous bid price shortfall.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025059084/0001213900-25-059084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000121390025059084/ea024719201-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer